TipHub

42.2

+0.12 +0.29%

As of 29 Jul 2026 · delayed

BSE Listed · Pharmaceuticals

ESM · ESM 1
What does ESM · ESM 1 mean?
BSE · Enhanced Surveillance Measure (ESM 1)ESM is the micro/small-cap ramp brake: it fires when a sub-₹1000cr stock's price variation is extreme versus its peer universe, or it's loss-making with a stretched valuation. Practical meaning: intraday speculation is shut off (Trade-for-Trade — every purchase must be taken to delivery), margins go to 100%, and at Stage II price discovery moves to periodic call auctions inside a 2% band.Criteria: Micro / small-cap companies (main-board market-cap below ₹500 cr) shortlisted on objective price parameters — high-low price variation, close-to-close price variation and standard deviation. Stage I = 100% margin + a ≤5% price band + Trade-for-Trade; Stage II = a 2% price band + periodic call auction.Exchange notice · 2026-07-08

Veerhealth Care Limited (511523)

Volume: 19,557Avg Vol 1W: 1,01,429Avg Vol 1M: 1,58,78352W Range:16.742.21
Key Ratios
Checked 1h ago
Market Cap₹84 Cr
Current Price₹42.2
Previous Close₹42.08
High / Low (52w)₹42.21 / ₹16.7
Volume19,557
Avg Vol (1W)1,01,429
Avg Vol (1M)1,58,783
Stock P/E124.12
Book Value₹11.46
Dividend Yield0%
ROE295.8%
ROA122.25%
Revenue (TTM)
Revenue Growth
Profit Margin166.2%
Total Debt
Shares Outstanding2 Cr
Face Value₹10
EPS (TTM)₹0.34
P/B3.68
Debt / Equity0.11
50 DMA₹31.39
200 DMA₹22.21
Day change+0.29%
SurveillanceESM · ESM 1
Price Chart
42.2 84.76% · 1Y
42179.9L
2025-07-29
2026-07-29

20-day avg volume: 1.5L shares

Pros
  • Healthy return on equity of 295.8%.
  • Company is almost debt-free.
  • Revenue grew 22% YoY.
Cons
  • Stock trades at a high P/E of 124.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹2 Cr₹5 Cr₹4 Cr₹6 Cr₹4 Cr₹4 Cr₹7 Cr₹17 Cr
EBITDA₹0 Cr₹1 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹1 Cr₹1 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EPS
Profit & Loss (Annual)
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹6 Cr₹6 Cr₹12 Cr₹12 Cr₹11 Cr₹15 Cr₹15 Cr₹18 Cr
EBITDA₹0 Cr₹0 Cr₹1 Cr₹1 Cr₹0 Cr₹1 Cr₹1 Cr₹1 Cr
Net Profit₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹2 Cr₹0 Cr₹0 Cr
EPS0.20.230.460.55-0.111.520.210.2
Balance Sheet
MetricMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹15 Cr₹16 Cr₹18 Cr₹19 Cr₹20 Cr₹25 Cr₹28 Cr₹34 Cr
Total Liabilities₹2 Cr₹3 Cr₹4 Cr₹5 Cr₹6 Cr₹4 Cr₹6 Cr₹12 Cr
Equity₹13 Cr₹13 Cr₹14 Cr₹14 Cr₹14 Cr₹21 Cr₹22 Cr₹22 Cr
Total Debt
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹1 Cr₹2 Cr₹-1 Cr₹3 Cr₹0 Cr
Investing₹0 Cr₹-1 Cr₹-2 Cr₹0 Cr₹-8 Cr
Financing₹-1 Cr₹0 Cr₹6 Cr₹-6 Cr₹10 Cr
Free Cash Flow₹1 Cr₹2 Cr₹0 Cr₹3 Cr₹0 Cr
Shareholding
Promoter 31.91% Institutions 0% Public 68.09%
Efficiency & Working Capital
ROCE6.6%
Interest Coverage3
Dividend Payout
Debtor Days70 d
Inventory Days54 d
Payable Days57 d
Cash Conversion Cycle66 d
Working Capital Days124 d
Shareholding Details

As of 2026-06-30

Promoter31.9%
FII0%
DII0%
Institutions0%
Public68.1%
Promoter Pledge0%
No. of Shareholders9,315
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Promoters30.8%30.8%30.4%30.4%30.4%30.4%31.5%31.5%31.5%31.5%31.5%31.9%
FIIs0%0%0%0%0%0%0%0%0%0%0%0%
DIIs0%0%0%0%0%0%0%0%0%0%0%0%
Public69.2%69.2%69.6%69.6%69.6%69.6%68.5%68.5%68.5%68.5%68.5%68.1%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders6,8186,87410,99110,25511,48911,46911,39011,01110,84610,45510,0279,315
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Yogesh Mahasuklal ShahShareholding of Promoter and Promoter Group12.2%24,45,070
Yogesh Shah HufShareholding of Promoter and Promoter Group4.2%8,41,114
Krupa Harsh JainShareholding of Promoter and Promoter Group4%7,90,062
Ruchi Yogesh ShahShareholding of Promoter and Promoter Group3.3%6,65,124
Shruti Akash ShahShareholding of Promoter and Promoter Group3.3%6,57,800
Rishabh FintradePublic Shareholding2.7%5,43,248
Samir . MehtaPublic Shareholding2%3,98,720
Shilpaben Alpeshbhai ShahPublic Shareholding1.5%3,08,600
Yash Alpeshbhai ShahPublic Shareholding1.5%2,99,600
Bhavin Satish ShahShareholding of Promoter and Promoter Group1.3%2,54,643
Alpa Sunil ChhedaPublic Shareholding1.1%2,20,000
Kalpana J. ShahPublic Shareholding1.1%2,18,459
Mahasuklal Shah HufShareholding of Promoter and Promoter Group1.1%2,15,000
Manushi Alpesh ShahPublic Shareholding1%2,07,500
Nisha Bhavin ShahShareholding of Promoter and Promoter Group0.9%1,79,026
Bhavin Satish Shah Huf .Shareholding of Promoter and Promoter Group0.8%1,64,400
Jigar Jayant ShahShareholding of Promoter and Promoter Group0.3%52,800
Ashish Jayant ShahShareholding of Promoter and Promoter Group0.3%49,900
Kalpana Dharnendra ShahShareholding of Promoter and Promoter Group0.2%43,974
Jayant Seventilal ShahShareholding of Promoter and Promoter Group0.1%11,524
Dharnendra Bipinchandra ShahShareholding of Promoter and Promoter Group0.1%10,500
Arvind M. Shah HufShareholding of Promoter and Promoter Group0%0
Divyabala M ShahShareholding of Promoter and Promoter Group0%0
Board of Directors
NameDesignationYear
Yogesh M ShahChairman & Non Executive Dir.2025
Bhavin S ShahManaging Director2025
Shruti A ShahExecutive Director2025
Chetan H MehtaIndependent Director2025
Prakash C ShahIndependent Director2025
Nilesh Kantilal ShahIndependent Director2025
Segments — Product
SegmentRevenueShare
Sale of Goods₹1 Cr100%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10452020
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025000155
2025000011
2025000145
Insider / Designated-Person Trades

14 recent disclosure(s)

Kalpana Dharnendra ShahDisposal · 50,000
Krupa Harsh JainAcquisition · 50,000
Krupa Harsh JainAcquisition · 43,462
Kalpana Dharnendra ShahDisposal · 1,00,000
Krupa Harsh JainAcquisition · 2,50,000
Kalpana Dharnendra ShahDisposal · 2,00,000
Substantial Acquisitions (SAST)

1 disclosure(s)

Market23/02/2024 · 5,00,000
Company Information
Incorporated1992
ChairmanYogesh M Shah
AuditorJayesh R Shah & Co
Investor Email[email protected]
🌐 www.veerhealthcare.net

📍 629-A 1st Floor Gazdar House, JSS Marg Nr Kalbadevi Post Off, Mumbai, Maharashtra, 400002

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search